FDA Class II Recall Targets 51,762 Units of ORL Oral Care Products for Hormone Contamination

3 min read
Source: Fox Business
FDA Class II Recall Targets 51,762 Units of ORL Oral Care Products for Hormone Contamination
Photo: Fox Business
TL;DR

ORL Labs LLC has voluntarily recalled 51,762 units of toothpaste and mouthwash nationwide after the FDA detected progesterone, estradiol, or DHEA in product samples. The recall, initiated in October and classified as Class II in November, involves six products, including items marketed for children. No illnesses have been reported, but consumers are advised to stop using affected lots.

Key points

  • The FDA initiated a Class II recall of 51,762 units of ORL Organic Oral Care products on October 12, with the classification finalized on November 6.
  • Testing revealed the presence of progesterone, estradiol, or dehydroepiandrosterone (DHEA) in samples, though specific concentrations and affected lots were not detailed in the initial report.
  • The recall includes three 4-ounce toothpaste varieties and three 16.9-ounce mouthwash varieties, with expiration dates ranging from September 2026 to August 2028.
  • Three of the six recalled products are marketed for children, raising concerns about potential exposure to sex hormones in young users.
  • No illnesses have been reported, and the FDA has not recommended routine medical testing for consumers who used the products.

Background

This recall follows a previous FDA warning in January 2026 regarding Signature Formulations, a manufacturer of ORL products, for cross-contamination issues on shared equipment. The current recall is part of a broader trend of oral care product recalls, including a separate Class II recall of Brush Buddies toothpaste in October 2026.

How outlets are covering it

Fox Business and USA Today reported the recall as a voluntary action by ORL Labs following FDA notification, emphasizing the lack of specific disposal instructions in the FDA report. Medical Daily highlighted the risks for children, noting that hormones like estradiol can cause developmental harm, and referenced a 2010 FDA warning about early puberty in children exposed to estradiol. NTD News provided additional context by comparing the recall to a separate October 2026 recall of Brush Buddies toothpaste, emphasizing the importance of Current Good Manufacturing Practices (cGMP). All sources agreed on the Class II classification and the number of units affected, but differed in their emphasis on health risks and regulatory context.

Why it matters

The recall highlights the importance of strict quality control in oral care products, especially those marketed for children. Hormone contamination can pose significant health risks, particularly for young children, and underscores the need for robust manufacturing practices to prevent cross-contamination. Consumers should check their products for affected lot numbers and discontinue use if necessary.

What to watch

ORL Labs has not issued a press release, and consumers are advised to contact the company for questions. The FDA may provide further details on the specific hormones and concentrations found in the samples. Consumers should monitor for any updates from the FDA or ORL Labs regarding the recall and potential health effects.

Share this article

Want the full story? Read the original reporting

Read on Fox Business